COVID-Aging: Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on Survival in Elderly Patients With COVID19: A Randomized, Multicenter, Double-Blind Study.
- Funded by Ministre des Solidarités et de la Santé (France)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
N/AFunder
Ministre des Solidarités et de la Santé (France)Principal Investigator
Frédéric BlancResearch Location
FranceLead Research Institution
N/AResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementationResearch Subcategory
Prophylactic use of treatmentsSpecial Interest Tags
N/AStudy Type
ClinicalClinical Trial Details
Randomized Controlled TrialBroad Policy Alignment
PendingAge Group
Adults (18 and older), Older adults (65 and older)Vulnerable Population
UnspecifiedOccupations of Interest
Unspecified